UK tops Quality of Death rankings
October 6, 2015Medical Communications NHS, ageing population, palliative care
The UK has ranked first in the 2015 Quality of Death Index, a measure of the quality of palliative care …
Cardinal Health completes $1.944bn acquisition of J&J’s Cordis
October 6, 2015Manufacturing and Production, Sales and Marketing Cardinal Health, Cordis, mergers and acquisitions
Cardinal Health has completed the acquisition of Johnson & Johnson’s Cordis business: a global leader in cardiology and endovascular devices, …
Pfizer axes lay-off plans and creates new jobs
October 6, 2015Manufacturing and Production Pfizer
A Pfizer facility in Ireland that was set to close has now been taken off the list of facilities no longer needed …
Desktop device synthesising lidocaine could revolutionise pharma manufacturing
October 6, 2015Manufacturing and Production lidocaine
A novel device with the ability to produce one of the most in-demand anaesthetics in any location may set the …
After Daraprim, Turing Pharma submits first in-house candidate to FDA
October 6, 2015Manufacturing and Production, Research and Development turing
Turing Pharma may have been on the end of some less-than-favourable media coverage in recent weeks, but the company is …
Teva acquires Mexico’s Rimsa for $2.3 billion
October 5, 2015Research and Development, Sales and Marketing Mexico, Rimsa, Teva, mergers and acquisitions
Strategic Move Enhances Teva’s Presence in Mexico, the Second Largest Market in Latin America and a Major Emerging Market Brings a Portfolio of …
North 51 acquired by Bionical
October 5, 2015Bionical, North 51, mergers and acquisitions
North 51 Ltd, a Nottingham-based healthcare company has been acquired by Bionical in a multi-million pound deal. The North 51 …
Why London is at the heart of life sciences
October 5, 2015Research and Development NHS
by Eliot ForsterWhatever disease you’re trying to cure, you can bet that somebody in London has it. That probably isn’t …
FDA approves Merck’s Keytruda for advanced NSC lung cancer
October 5, 2015Research and Development, Sales and Marketing BMS, NSCL, keytruda, lung cancer, merck sharp and dohme, opdivo
The US Food and Drug Administration has granted accelerated approval for Merck’s Keytruda (pembrolizumab) to treat patients with advanced (metastatic) …
Pfizer completes $130 million purchase of two GSK vaccines
October 5, 2015Sales and Marketing GSK, Pfizer, meningitis
Pfizer has announced that it has completed the $130 million acquisition of GlaxoSmithKline’s quadrivalent meningococcal ACWY vaccines Nimenrix and Mencevax. …
David Cameron pledges seven-day GP service by 2020
October 5, 2015Medical Communications NHS, david cameron
Millions of patients will benefit from ground-breaking plans for seven-day access to both their GPs and hospitals, British Prime Minister …
Hillary Clinton takes aim at pharma industry in White House bid
October 5, 2015Medical Communications, Sales and Marketing turing
Hillary Clinton has taken aim at the pharmaceutical industry with a campaign advert airing in two US states, in which …
New partnership will speed medical diagnoses through crowdsourcing
October 5, 2015Medical Communications, Sales and Marketing Global Genes, Sermo
The global social network for physicians, SERMO, is partnering with Global Genes, a leading rare disease patient advocacy organisation, to provide …
Woodley Equipment to Attend Global Site Solutions Summit, Florida, USA
October 2, 2015Manufacturing and Production, Research and Development woodley equipment
Woodley Equipment will attend the upcoming Global Site Solutions Summit in Florida, USAThe Global Site Solutions Summit is taking place …
Home Secretary Theresa May opens Abbvie’s new UK offices
October 2, 2015Medical Communications AbbVie
AbbVie today opened new UK offices, in a ceremony presided over by Theresa May, Home Secretary and MP for Maidenhead.The company, …
Professor Stephen Gough joins Novo Nordisk as senior principal clinical scientist
October 2, 2015Medical Communications, Research and Development Novo Nordisk, Professor Stephen Gough
Novo Nordisk has announced that Professor Stephen Gough, a renowned clinical and research specialist in diabetes, joined the company today …
Genzyme opts into Alnylam’s Thrombosis program
October 2, 2015Medical Communications, Research and Development Alnylam, Genzyme, Sanofi, haemophilia
Sanofi subsidiary Genzyme has elected to opt into Alnylam’s investigational ALN-AT3 hemophilia program for development and potential future commercialisation in …
Legal analysis: a summary of the Lyrica pregabalin case and the issue of cross-label use in Europe
October 2, 2015Medical Communications Lyrica, Pfizer
The Warner Lambert v Actavis pregabalin cases have been before the UK Courts on no less than seven occasions since the beginning of …
Survey finds GPs have negative views of pharma
October 2, 2015Medical Communications
A survey by healthcare data and intelligence provider Binley’s has found that more than 40% of GPs have a negative …
FDA accepts Sandoz submission for Amgen biosimilar
October 2, 2015Medical Communications, Research and Development Amgen, FDA, Novartis, Sandoz, biosimilars
Sandoz, a Novartis company and a global leader in biosimilars, has announced today that the US Food and Drug Administration …
Latest content
Migraine annual economic and quality-of-life burden in UK
bit.bio expands human heart cell portfolio through myriamed partnership
Phoenix Labs acquires Kent Pharma
Astoriom acquires Sampled’s UK stability storage operations
